Dual targeting agent Thiotert inhibits the progression of glioblastoma by inducing ER stress-dependent autophagy

Biomed Pharmacother. 2024 Jan:170:115867. doi: 10.1016/j.biopha.2023.115867. Epub 2023 Dec 15.

Abstract

Glioblastoma (GBM) is the most aggressive and lethal type of tumor in the central nervous system, characterized by a high incidence and poor prognosis. Thiotert, as a novel dual targeting agent, has potential inhibitory effects on various tumors. Here, we found that Thiotert effectively inhibited the proliferation of GBM cells by inducing G2/M cell cycle arrest and suppressed the migratory ability in vitro. Furthermore, Thiotert disrupted the thioredoxin (Trx) system while causing cellular DNA damage, which in turn caused endoplasmic reticulum (ER) stress-dependent autophagy. Knockdown of ER stress-related protein ATF4 in U251 cells inhibited ER stress-dependent autophagy caused by Thiotert to some extent. Orthotopic transplantation experiments further showed that Thiotert had the same anti-GBM activity and mechanism as in vitro. Conclusively, these results suggest that Thiotert induces ER stress-dependent autophagy in GBM cells by disrupting redox homeostasis and causing DNA damage, which provides new insight for the treatment of GBM.

Keywords: Autophagy; DNA damage; ER stress; GBM; Thiotert; Trx system.

MeSH terms

  • Apoptosis
  • Autophagy
  • Brain Neoplasms* / genetics
  • Cell Line, Tumor
  • Endoplasmic Reticulum Stress
  • G2 Phase Cell Cycle Checkpoints
  • Glioblastoma* / metabolism
  • Humans